NASDAQ · Biotechnology

Sol-Gel Technologies Ltd. (SLGL) Stock

$70.34 -2.23% NASDAQ: SLGL Healthcare

Valuation

MetricValue
Price$70.34
Market Cap$229.94M
P/E Ratio-12.77
P/B Ratio4.90
P/S Ratio131.12
EPS (TTM)$-2.20
52-Week High$97.97
52-Week Low$28.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-44.05%
ROA-30.39%
ROCE-36.28%
Gross Margin-42.11%
Operating Margin-42.11%
Net Margin-910.14%
Debt/Equity0.02
Current Ratio4.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$31.0M$4.0M$2.0M$12.0M$19.0M
Operating Profit$3.0M$-16.0M$-29.0M$-12.0M$-8.0M
Net Profit$3.0M$-15.0M$-27.0M$-11.0M$-6.0M
EPS$0.14$-0.65$-10.01$-3.79$-2.20
Op Margin9.5%-418.3%-1885.8%-104.1%-38.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$69.0M$47.0M$45.0M$36.0M$30.0M
Total Liabilities$14.0M$4.0M$7.0M$7.0M$7.0M
Cash$20.0M$12.0M$8.0M$19.0M$11.0M
Borrowings$2.0M$1.0M$2.0M$1.0M$1.0M

Latest News

Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates Zacks · May 28, 2026 Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates GlobeNewswire · May 28, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-8.0M$-9.0M$-18.0M$-14.0M$0
Investing Cash Flow$20.0M$2.0M$-10.0M$27.0M$-9.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$13.0M$-8.0M$-6.0M$13.0M$-8.0M
Free Cash Flow$-8.0M$-10.0M$-18.0M$-14.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.35
EV / EBITDA-12.64
FCF Yield0.00%
Quick Ratio10.37
Interest Coverage0.00
Return 1Y710.36%
Return 3Y107.60%
Return 5Y-39.00%

Ownership

Insiders Held59.70%
Institutions Held37.37%
Institutions Float Held92.73%
Institutional HolderSharesReport Date
Opaleye Management Inc.500,0002026-03-31
Great Point Partners LLC274,3632026-03-31
Phoenix Financial Ltd.210,8492026-03-31
Trails Edge Capital Partners, LP85,4962026-03-31
Citadel Advisors Llc37,1452026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANEBAnebulo Pharmaceuticals, Inc. $0.34 +0.00% -1.73 $13.72M 0.00%
CLNNClene Inc. $3.88 -1.02% -1.10 $49.58M 0.00%
COYACoya Therapeutics, Inc. $4.99 +1.63% -4.53 $117.05M 0.00%
MGNXMacroGenics, Inc. $3.55 +0.00% -16.25 $225.65M 0.00%
OKYOOKYO Pharma Limited $1.39 -2.73% -6.15 $53.33M 0.00%

About Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd. is led by CEO Moshe Arkin, employs 34 people, headquartered in IL, publicly traded since 2018.

Sol-Gel Technologies Ltd. (SLGL) stock trades at $70.34 with a market capitalization of $229.94M. The stock is valued at a price-to-earnings (P/E) ratio of -12.77, price-to-book of 4.90, price-to-sales of 131.12. Over the past 52 weeks the stock has ranged between $28.50 and $97.97, and currently trades 28.2% below its 52-week high.

On profitability, Sol-Gel Technologies Ltd. generates a return on equity (ROE) of -44.05%, return on capital employed of -36.28%, an operating margin of -42.11%, a net profit margin of -910.14%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides